Navigation Links
Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
Date:3/27/2008

h, cell differentiation and cell survival. KRX-0401, which is currently in Phase 2 clinical development for multiple tumor types, is expected to move into a Phase 3 clinical program in 2008. The Company also has an active in-licensing and acquisition program designed to identify and acquire additional drug candidates. Keryx is headquartered in New York City.

Cautionary Statement

As the Company has indicated in its public filings, among other things, clinical trials have a high risk of failure. A number of companies in the pharmaceutical industry, including biotechnology companies, have suffered significant setbacks in advanced clinical trials, even after achieving what appeared to be promising results in earlier trials.

Furthermore, as indicated in previous filings, interim results of preclinical or clinical studies do not necessarily predict their final results, and acceptable results in early studies might not be obtained in later studies. Drug candidates in the later stages of clinical development may fail to show the desired safety and efficacy traits despite positive results in initial clinical testing.

Additionally, as indicated in previous filings, there can be no assurance that the results from the Sulonex Phase 3 and/or Phase 4 study will track the data from the pilot Collaborative Study Group Phase 2 study or the DiNAS Phase 2 study. Results from these earlier Sulonex studies may not be indicative of results from future clinical trials.

Some of the statements included in this press release anticipating future clinical and business prospects may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Among the factors that could cause our actual results to differ materially are the following: our ability to successfully adjust our strategy
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
2. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
3. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
4. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
7. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
8. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
11. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- By now, if you haven,t heard about the ALS ... The awareness campaign has brought this devastating disease to the ... $88.5 Million (and counting) for ALS. Every day, more and ... to as well. One such company, Acorn Stairlifts ... actually works with ALS sufferers and helps to provide solutions ...
(Date:8/27/2014)... Holdings, Inc. (NYSE: HRC ) invites you ... Stanley Global Healthcare Conference on September 8, 2014, at ... listen to the live discussion via the internet link ... http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the discussion ... live event and accessible at the links above until ...
(Date:8/27/2014)... -- North American lighting leader OSRAM SYLVANIA has ... new OSRAM ITOS ® PHASER ® 3000, the ... endoscopy and surgical head lamps that delivers the same brightness ... life. "We,re honored to be recognized by ... technologies of the past year," said Andreas Osten , ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... , , REDWOOD CITY, Calif. , ... separate collaborations in pharmaceutical manufacturing with Dishman Pharmaceuticals and ... of American Pacific Corporation. These agreements expand the application ... innovator pharmaceutical products. , Under the new agreements, ...
... , Rowinsky to Serve on RRD International,s ... Feb. 17 RRD International, a strategy-driven ... Eric Rowinsky , M.D. will oversee oncology product ... Advisory Board.  Dr. Rowinsky is a highly accomplished cancer ...
Cached Medicine Technology:Codexis Expands Pharmaceutical Manufacturing Partnerships 2Codexis Expands Pharmaceutical Manufacturing Partnerships 3Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International 2Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International 3
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 ... small and mid-sized healthcare organizations, today announced that it ... online appointment company ZocDoc , to head their ... company has created a sales management position. , “I’m ... startup like DoctorBase that already has so much traction ...
(Date:8/28/2014)... Tea Leaves Health is pleased ... leader in Connected Consumer Management. By integrating Gigya’s ... the opportunity to build more authentic relationships with ... and how they like to interact. , Gigya’s ... brands to understand and connect with mobile and ...
(Date:8/28/2014)... Hanover, MA (PRWEB) August 28, 2014 Now ... a run/walk that was started in 2011 by two brain ... to raise much needed awareness, provide education to help increase ... have been impacted by a brain aneurysm. We hope that ... support a worthy cause at the 4th Annual Step for ...
(Date:8/28/2014)... Texas (PRWEB) August 28, 2014 MMAR ... The program is a chance for regular customers to ... Medical without the need for a wholesale license. It’s ... coaches, semi-professional athletic programs and others who regularly purchase ... , “Whether supporting your own active lifestyle or ...
(Date:8/28/2014)... The revenue cycle process touches on ... time a patient books an appointment with a physician’s ... payments for services rendered to the healthcare provider. ... has the RCM process down to a science. Over ... common place in nearly every healthcare facility around the ...
Breaking Medicine News(10 mins):Health News:DoctorBase Hires Josh Angeles as Vice-President of Sales 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 2Health News:Tea Leaves Health Begins Important New Partnership with Gigya 3Health News:Step for Hope and Raise Brain Aneurysm Awareness 2Health News:MMAR Medical Announces Customer Membership Program 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 2Health News:Tips on Automating the Revenue Cycle Process with Medical Billing 3
... & plc (NYSE/LSE: CCL; NYSE CUK) today announced a ... majority of which will be incurred in the second ... to cruise itineraries for the six-week period ended June ... Control (CDC) recommendation against non-essential travel to Mexico. The ...
... The National Autism Association (NAA) announced today ... agencies for Project Lifesaver Equipment through the organization,s FOUND ... County Utah Sheriff,s Department will both receive grants for ... children with autism at high risk for wandering. FOUND ...
... Lialda(R) (mesalamine) or Pentasa(R) (mesalamine) for the Treatment of ... May 18 Shire plc (LSE: SHP, Nasdaq: ... responding to the needs of patients who are diagnosed ... from Shire by expanding its Patient Assistant Program (PAP). ...
... EventBOSTON, May 18 AMR Research , ... and its supporting technologies, today announced the final agenda for ... The Phoenician Resort in Scottsdale, Arizona, May 27-29, 2009. ... of Walt Disney Companies from 1984-2005, and the release of ...
... says , , MONDAY, May 18 (HealthDay News) -- A new ... patients moist and clear, researchers say. , Using a special ... too quickly, which is a common problem for people with ... of the airway causes their airways to dry, and allows ...
... no more dangerous than regular flu , , MONDAY, May 18 ... City public school died Sunday night of complications from the ... States to die from the disease that was first identified ... death was not surprising, because even a normal flu season ...
Cached Medicine News:Health News:Carnival Corporation & plc Reports Financial Impact of Itinerary Changes Responding to H1N1 Influenza Mexico Travel Advisory; Plans Rapid Return to Popular Mexican Ports 2Health News:National Autism Association Provides Funds to Law Enforcement Agencies in Staunton, Virginia and Summit County, Utah for Project Lifesaver Equipment 2Health News:Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans 2Health News:Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans 3Health News:Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans 4Health News:Shire Expands Gastrointestinal Patient Assistance Program for Uninsured or Unemployed Americans 5Health News:AMR Research Announces Final Agenda for Sold-Out Supply Chain Executive Conference 2Health News:New Spray Could Benefit Cystic Fibrosis Patients 2Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 2Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 3Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 4Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 5Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 6Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 7Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 8Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 9Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 10Health News:NYC School Assistant Principal Is Latest Swine Flu Fatality 11
Digital Ultrasonic Diagnostic Imaging System...
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Pefakit PiCT LMWH Controls...
Calcium Chloride 0.020M - 4 ml...
Medicine Products: